+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immune Pharmaceuticals - logo

Immune Pharmaceuticals is a clinical stage biopharmaceutical company that develops novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas. The company's lead product candidate is Bertilimumab, a human monoclonal antibody, which is in Phase II clinical trial for the treatment of ulcerative colitis, bullous pemphigoid, and Crohn's disease. Immune Pharmaceuticals, Inc. was founded in 2010 and is headquartered in New York, New York.

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020 - Product Thumbnail Image

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 2815 Pages
  • Global
From
Alpha Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Alpha-1 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha-1 Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2020 - Product Thumbnail Image

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 103 Pages
  • Global
From
Competitor Landscape: Non-alcoholic Steatohepatitis (NASH) - Product Thumbnail Image

Competitor Landscape: Non-alcoholic Steatohepatitis (NASH)

  • Report
  • November 2018
  • 52 Pages
  • Global
From
From
Loading Indicator